Sign in Subscribe
United States. Securities and Exchange Commission

Humacyte, Inc. Files SEC Form S-3, Simplified Registration

Strategic Insights

— 1 min read

Humacyte, Inc. has filed a simplified registration form with the U.S. Securities and Exchange Commission (SEC), indicating its intentions to raise capital or engage in other financial activities. The filing, noted in a SEC document on June 9, 2023, reflects the company's status as a biopharmaceutical entity, categorized under the SIC code 2836 for biological products excluding diagnostic substances. This filing is particularly noteworthy as it specifies the use of Form S-3, a simplified registration form reserved for companies with a history of timely SEC filings and meeting specific eligibility criteria. This development may have significant implications for Humacyte, Inc. and its investors, as it paves the way for a potentially streamlined financial process.

Key Takeaways:

  • Humacyte, Inc. has filed SEC Form S-3, indicating intentions to engage in financial activities like raising capital.
  • The company is categorized under SIC code 2836, which includes biological products excluding diagnostic substances.
  • This is a simplified registration form, typically used by companies that have met specific eligibility criteria.
  • Form S-3 can only be used by companies that have been required to report under the "34 Act" for a minimum of 12 months and have a history of timely filings.
  • This filing may have implications for Humacyte's financial process and its relationship with investors.

Statistics:

  • 8 documents were filed with the SEC Form S-3.
  • The SEC file number for this filing is 0001818382-23-000039.
  • The contact information for Humacyte, Inc. includes a physical address at 2525 East North Carolina Highway 54, Durham, NC 27713, and a phone number of 919-313-9633.
  • The simplified registration form was filed on June 2023.

Sources:

  • NewsRx staff, "U.S. Securities and Exchange Commission Filing by Humacyte, Inc. - Form S-3 - NewsRx," June 28, 2023.
  • U.S. Securities and Exchange Commission, "Humacyte, Inc. (0001818382) - Form S-3 - June 9, 2023."
  • SEC.gov, "Form S-3, Simplified Registration," accessed June 28, 2023.
  • NewsRx LLC, "Financial information on Humacyte, Inc. filing, accessed June 28, 2023."

Read more